Study: Additional radiation for liver cancer does not increase toxicity

AI Summary

A University of Cincinnati Cancer Center study found that external beam radiation therapy (EBRT) is safe to use in liver cancer patients who have already received Y90 targeted internal radiation. The research suggests combining both therapies does not increase toxicity, potentially expanding treatment options for patients.

New research from a University of Cincinnati Cancer Center study found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.